Compare GRML & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | GRML | ATCH |
|---|---|---|
| Founded | N/A | 2022 |
| Country | United States | United States |
| Employees | 5 | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.9M | 29.6M |
| IPO Year | 2022 | 2024 |
| Metric | GRML | ATCH |
|---|---|---|
| Price | $0.23 | $0.19 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | ★ 3.3M | 1.4M |
| Earning Date | 05-13-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $84.47 |
| Revenue Next Year | N/A | $39.32 |
| P/E Ratio | ★ N/A | $3.88 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.21 | $0.14 |
| 52 Week High | $0.55 | $1.92 |
| Indicator | GRML | ATCH |
|---|---|---|
| Relative Strength Index (RSI) | 33.51 | 41.77 |
| Support Level | $0.21 | $0.19 |
| Resistance Level | $0.34 | $0.22 |
| Average True Range (ATR) | 0.04 | 0.01 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 16.57 | 25.65 |
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.